Metraipolis › archive › dc_9d44923dcd22

Comparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory Authorities — Europe PMC PMID:39306603

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39306603
DOI
10.1007/s43441-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-08T00:33:22.228Z
SHA-256 of the archived text
1d70aadc4ced1c2e0d314478f46197b075a31c90a2e5e1335044fb5d26c31abe
Stable URL of this page
https://metraipolis.com/documento/dc_9d44923dcd22

How to cite

Comparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory Authorities — Europe PMC PMID:39306603 — Europe PMC (en), https://europepmc.org/article/MED/39306603 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9d44923dcd22 (Metraipolis archive dc_9d44923dcd22, sha256 1d70aadc4ced1c2e0d314478f46197b075a31c90a2e5e1335044fb5d26c31abe)
BibTeX
@misc{dc9d44923dcd22,
  title = {Comparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory Authorities — Europe PMC PMID:39306603},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39306603},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9d44923dcd22; sha256 1d70aadc4ced1c2e0d314478f46197b075a31c90a2e5e1335044fb5d26c31abe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39306603. Agents can read the archived copy with the MCP tool read_document.